Limited Progress on QoL Goals Reported for Persons With HIV Aged 50 Years and Older
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Sept. 13, 2024 -- For persons diagnosed with HIV (PWH) aged 50 years and older, progress on quality of life (QoL) goals is limited, according to a study published online Sept. 12 in Morbidity and Mortality Weekly Report.
Linda Beer, Ph.D., from the U.S. Centers for Disease Control and Prevention, and colleagues examined progress toward goals for improving QoL, established as a priority of the National HIV/AIDS Strategy for PWH, among PWH aged 50 years and older. Progress was assessed using data collected during the 2017 to 2022 cycles of the Medical Monitoring Project. The recent estimated annual percentage change from baseline to 2022 was calculated for each of five indicators: self-rated health, unmet needs for mental health services, unemployment, hunger or food insecurity, and unstable housing or homelessness.
The researchers found that the 2025 goal of 95 percent PWH with good or better self-rated health is 46.2 percent higher than the 2022 estimate, while the 2025 goals of a 50 percent reduction in the other indicators varied from 26.3 to 56.3 percent lower than the 2022 estimates. The only goal met by 2022 was a 50 percent reduction in hunger or food insecurity among PWH aged 65 years and older. Other QoL 2025 goals are unlikely to be met if recent trends continue.
"CDC will continue to monitor QoL among PWH to identify areas for intervention. This information can be used to direct multisectoral implementation of programmatic efforts and guide future goals for improving health and well-being among older PWH," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-09-14 12:00
Read more
- Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
- Satsuma Pharmaceuticals and SNBL Resubmits the New Drug Application for STS101 (Dihydroergotamine Nasal Powder) for the Acute Treatment of Migraine With or Without Aura
- Nasal Swab Might Predict How Severe COVID Will Be
- Being Born Preterm Tied to Lifelong Harms in Employment, Education
- A Cancer Diagnosis Takes Devastating Toll on Family Finances
- Kids Still Find It Easy to Buy Flavored Vapes Online
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions